• OPEN AN ACCOUNT
Indian Indices
Sensex
78,094.64 166.49
( 0.21%)
Global Indices
Nasdaq
52,497.89 268.83
(0.51%)
Dow Jones
7,510.69 52.06
(0.70%)
Hang Seng
64,316.33 2,448.90
(3.96%)
Nikkei 225
10,879.26 -18.01
(-0.17%)
Forex
USD-INR
95.59 -0.10
(-0.11%)
EUR-INR
109.79 0.65
(0.59%)
GBP-INR
128.11 0.75
(0.59%)
JPY-INR
0.59 0.01
(1.09%)

EQUITY - MARKET SCREENER

Parmax Pharma Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
540359
INE240T01014
-18.3323978
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
39.2
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 

simplex papers ltd
3B Blackbio DX consolidated net profit rises 13.81% in the March 2026 quarter
May 29,2026
Net profit of 3B Blackbio DX rose 13.81% to Rs 9.56 crore in the quarter ended March 2026 as against Rs 8.40 crore during the previous quarter ended March 2025. Sales rose 57.47% to Rs 35.43 crore in the quarter ended March 2026 as against Rs 22.50 crore during the previous quarter ended March 2025.

For the full year,net profit rose 22.96% to Rs 58.59 crore in the year ended March 2026 as against Rs 47.65 crore during the previous year ended March 2025. Sales rose 47.11% to Rs 141.92 crore in the year ended March 2026 as against Rs 96.47 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales35.4322.50 57 141.9296.47 47
OPM %23.9635.20 -40.0051.94 -
PBDT18.5412.82 45 82.1065.08 26
PBT14.6512.54 17 76.9764.00 20
NP9.568.40 14 58.5947.65 23